ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,856.78
0.70%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Charles River Laboratories International Inc (CRL)

  7. Charles River Laboratories International Inc (CRL) Noticias

CRL Charles River Laboratories International Inc

229.03
1.22 (0.54%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Charles River Laboratories International Inc CRL NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
1.22 0.54% 229.03 18:18:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
227.39 227.39 230.86 229.03 227.81
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202407:00BWCharles River Laboratories Achieves 100% Renewable..
16/4/202407:00BWCharles River Laboratories Launches Alternative Methods..
12/4/202407:00BWCharles River Laboratories Schedules First-Quarter 2024..
11/4/202407:00BWCharles River and Deciphex Launch Patholytix Foresight, a..
09/4/202407:00BWCharles River Announces Rare Disease Gene Therapy..
04/4/202407:00BWCharles River to Perform Plasmid Production for Ship of..
01/4/202407:00BWCharles River Laboratories Showcases Technology-Driven..
27/3/202407:00BWCharles River Laboratories Publishes 2023 Corporate..
21/3/202407:00BWCharles River Announces Extension of Gene Therapy..
14/3/202407:00BWCharles River and Navega Therapeutics Announce Comprehensive..
12/3/202407:00BWCharles River Laboratories to Present at Barclays Global..
11/3/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202413:34EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202411:47EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:14EDGAR2Form 144 - Report of proposed sale of securities
29/2/202411:42EDGAR2Form 144 - Report of proposed sale of securities
29/2/202401:00PRNUSWheeler Bio Seals Agreement with Charles River to Offer..
23/2/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202410:09EDGAR2Form 144 - Report of proposed sale of securities
21/2/202407:00BWCharles River and Wheeler Bio Complete Agreement to..
20/2/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202407:08BWCharles River Collaborates with Pluristyx, Expanding its..
16/2/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:04EDGAR2Form 144 - Report of proposed sale of securities
15/2/202410:02EDGAR2Form 144 - Report of proposed sale of securities
14/2/202406:30EDGAR2Form 8-K - Current report
14/2/202406:00BWCharles River Laboratories Announces Fourth Quarter and..
05/2/202419:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:34EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
31/1/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202407:00BWCharles River Introduces the First Rapid Animal-Free..
24/1/202415:34EDGAR2Form 8-K - Current report
24/1/202415:30BWCharles River Laboratories Adds Reshema Kemps-Polanco to..
23/1/202415:30BWCharles River Laboratories Schedules Fourth-Quarter 2023..
16/1/202415:32EDGAR2Form 8-K - Current report
16/1/202407:00BWCharles River Launches Rep/Cap Plasmids to Streamline..
11/1/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:00BWCharles River Laboratories to Present at J.P. Morgan..

Su Consulta Reciente

NYSE
CRL
Charles River Laboratories
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados